Brentwood, United Kingdom

David Edward Clark


Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 67(Granted Patents)


Location History:

  • Dagenham, GB (2002)
  • West Malling, GB (2003)
  • Brentwood, GB (2003 - 2004)

Company Filing History:


Years Active: 2002-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of David Edward Clark

Introduction

David Edward Clark is a distinguished inventor based in Brentwood, GB, known for his contributions to the pharmaceutical field. With a total of four patents to his name, Clark has made significant strides in drug development, particularly in creating compounds that target integrin antagonists.

Latest Patents

Clark's latest patents include the innovative "Substituted Bicyclic Heteroaryl Compounds and Their Use as Integrin Antagonists" and "Substituted Benzoxazole Compounds." These inventions exemplify his expertise in medicinal chemistry and his commitment to advancing therapeutic options.

Career Highlights

Currently, David Edward Clark is employed at Aventis Pharma Limited, where he has been instrumental in advancing research and development projects. His work contributes to the company's mission to create effective pharmaceuticals that can aid in the treatment of various health conditions.

Collaborations

Throughout his career, Clark has had the privilege of collaborating with notable colleagues such as Paul Robert Eastwood and Neil Victor Harris. These partnerships have fostered an environment of innovation and shared knowledge, enhancing the impact of their collective work.

Conclusion

David Edward Clark stands out as a remarkable inventor whose work continues to influence the world of pharmaceuticals. His patents reflect a dedication to developing novel compounds that hold promise for future medical applications, ensuring that his legacy in innovation will be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…